Format

Send to

Choose Destination
Cell Cycle. 2017 Jun 3;16(11):1053-1062. doi: 10.1080/15384101.2017.1312224. Epub 2017 Apr 12.

Nrf2 promotes progression of non-small cell lung cancer through activating autophagy.

Author information

1
a Department of Oncology , The First Affiliated Hospital of Xi'an Jiaotong University , Xi'an , Shaanxi Province , P. R. China.
2
b Department of Respiration, Department of Respiratory Medicine , Xi'an Central Hospital , Xi'an , Shaanxi Province , P. R. China.
3
c Department of Respiration , The First Affiliated Hospital of Xi'an Jiaotong University , Xi'an , Shaanxi Province , P. R. China.
4
d Department of Oncology , The Second Affiliated Hospital of Xi'an Jiaotong University , Xi'an , Shaanxi Province , P. R. China.
5
e Department of General Surgery , The Second Affiliated Hospital of Xi'an Jiaotong University , Xi'an , Shaanxi Province , P. R. China.

Abstract

The transcription factor, NFE2-related factor 2 (Nrf2) and autophagy have been implicated in the oxidative-stress response during tumor evolution. However, few studies focus on crosstalk between Nrf2 and autophagy in cancer progression of non-small cell lung cancer (NSCLC). Herein, we evaluated the effect of Nrf2 on autophagy in NSCLC and their role in development of NSCLC. Effect of Nrf2 on overal survival (OS) of NSCLC patients were evaluated. Cell biological behaviors in response to Nrf2 were evaluated by MTT, colony formation assay and flow cytometry. Effect of 3-MA (a classical inhibitor of autophagy) on 95D-Nrf2 cells was also analyzed using flow cytometry. After up/down-regulating Nrf2 in NSCLC cell lines, expression of autophagy-related proteins were evaluated with western blot analysis. The results revealed that Nrf2 was an independent prognositc factor negtively associated with OS of NSCLC patients. Elevated Nrf2 expression promotes NSCLC progression, enhancing the escape of tumor cells from apoptosis in vivo and in vitro. Double staining with Annexin V-APC and 7-AAD showed that the proportions of apoptotic cells in 95D-Nrf2 cells were gradually increased after the addition of 3-MA. Importently, Nrf2 induced autophagosome formation and enhanced autophagic activity, which subsequently inhibits NSCLC cell apoptosis. In conclusion, our present study demonstrates that Nrf2 promotes progression of non-small cell lung cancer through activating autophagy. It provides novel insights into Nrf2-mediated of cell proliferation in NSCLC and may facilitate therapeutic development against NSCLC.

KEYWORDS:

Nrf2; apoptosis; autophagy; cell proliferation; lung cancer

PMID:
28402166
PMCID:
PMC5499849
DOI:
10.1080/15384101.2017.1312224
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center